Cantor Fitzgerald last night downgraded Korro Bio (KRRO) to Neutral from Overweight without a price target after the company’s lead asset KRRO-110 failed. Cantor now sees a “long journey ahead” for Korro.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO: